Adopted Reflection Paper Use Extrapolation Development ...
in the development of medicines for children. The focus of the paper is on the use of ext rapolation to address one or more specific research question s, related to either efficacy or safety, that are part of a broader paediatric development plan aimed at MA . The paper aims to promote the use of available
Download Adopted Reflection Paper Use Extrapolation Development ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
Land-Use Planning & Development Control: Planning For …
www.iaqm.co.ukthe members of the Working Group. We encourage the use of the materials but request that acknowledgement of the source is explicitly stated. All design rights are held by the IAQM, unless otherwise stated. Suggested citation: Moorcroft and Barrowcliffe. . (2017) et al Land-use Planning & Development Control: Planning for Air Quality. v1.2 ...
Social Development: Why It Is Important and How To Impact It
www.edpsycinteractive.orgrelated to the development of social competence and provides a literature review of theory and research supporting the vital importance of social competence, including a discussion of empirically-based interventions and measurement tools that educators can use to …
High-Rise Building Definition, Development, and Use
booksite.elsevier.comDefinition, Development, and Use The interesting question is why does man want to build to the sky. What is there about the desire for domination, or to reach God, or for private pride — the Pyramids are an example of that, but the tall building is certainly another. — Skyscrapers Introductory Interview with Philip Johnson 1
DEVELOPMENT STANDARDS FOR RESIDENTIAL MIXED-USE …
www.acgov.orgThis chapter presents standards for residential mixed-use projects in the Ashland and Cherryland Business District and the Castro Valley Central Business District. Although there are several different types of mixed-use develop-ment, this chapter only addresses mixed-use development that includes residential uses. Section 4.1 discusses the
Mixed Use and Mixed Income Housing Development
archives.huduser.govUse Projects Mixed-use projects, particularly those that incorporate some element of affordable housing, often face both “cost gaps” and “affordability gaps” associated with both the housing and the commercial uses. Cost gaps = the difference between the cost of development and what the market is willing to finance.
Guideline on pharmaceutical development of medicines for ...
www.ema.europa.euof paediatric medicines (either generic, innovative, existing or new), the speed of development, industrial feasibility and the need to develop medicin al products that are more appropriate for use in children, rather than continuing the practice of unapproved, pharmacy compounded medicines and off-label use.
Mixed Use Development: A Review of the Literature
www.cdfa.netA mixed-use development is a real estate project with planned integration of some combination of retail, office, residential, hotel, recreation or other functions. It is pedestrian-oriented and contains elements of a live-work-play environment. It maximizes
Application for a Lawful Development Certificate for an ...
ecab.planningportal.co.ukdevelopment or an existing use of land, or any other matter constituting a failure to comply with any condition or limitation subject to which planning permission has been granted, is lawful, and if so, be granted a certificate to that effect.